RNA-binding proteins in Mendelian disease

Trends in Genetics

Volumn 29, Issue 5, 2013, Pages 318-327

  Castello, Alfredo ^a   Fischer, Bernd ^a   Hentze, Matthias W ^a   Preiss, Thomas ^b  

^a EUROPEAN MOLECULAR BIOLOGY LABORATORY   (Germany)

^b Biology and Environment   (Australia)

Author keywords

Disease genetics; Gene set enrichment; Interactome capture; Mass spectrometry; MRNA metabolism; Proteomics; RNA binding domain; RNA binding protein

Indexed keywords

INITIATION FACTOR 4E; MESSENGER RNA; RIBONUCLEOPROTEIN; RIBOSOME RNA; RNA BINDING PROTEIN; TRANSFER RNA;

3' UNTRANSLATED REGION; COMPLEX FORMATION; GENETIC ASSOCIATION; GENETIC DISORDER; HELA CELL; HUMAN; IN VIVO STUDY; MASS SPECTROMETRY; MENDELIAN DISEASE; MUTATIONAL ANALYSIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN CROSS LINKING; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN METABOLISM; PROTEIN MOTIF; PROTEIN SYNTHESIS; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSCRIPTION REGULATION; ULTRAVIOLET IRRADIATION;

GENETIC DISEASES, INBORN; HUMANS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN STRUCTURE, TERTIARY; RNA, MESSENGER; RNA-BINDING PROTEINS;

EID: 84876806808     PISSN: 01689525     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tig.2013.01.004     Document Type: Review

References (80)

1. Glisovic T., et al. RNA-binding proteins and post-transcriptional gene regulation. FEBS Lett. 2008, 582:1977-1986.
2. Gebauer F., et al. From cis-regulatory elements to complex RNPs and back. Cold Spring Harb. Perspect. Biol. 2012, 4:a012245.
3. Keene J.D. RNA regulons: coordination of post-transcriptional events. Nat. Rev. Genet. 2007, 8:533-543.
4. Mayr C., Bartel D.P. Widespread shortening of 3'UTRs by alternative cleavage and polyadenylation activates oncogenes in cancer cells. Cell 2009, 138:673-684.
5. Wang E.T., et al. Alternative isoform regulation in human tissue transcriptomes. Nature 2008, 456:470-476.
6. Danckwardt S., et al. p38 MAPK controls prothrombin expression by regulated RNA 3' end processing. Mol. Cell 2011, 41:298-310.
7. Hynes C., et al. miRNAs in cardiac disease: sitting duck or moving target?. IUBMB Life 2012, 64:872-878.
8. Cooper T.A., et al. RNA and disease. Cell 2009, 136:777-793.
9. Lukong K.E., et al. RNA-binding proteins in human genetic disease. Trends Genet. 2008, 24:416-425.
10. Darnell R.B. RNA regulation in neurologic disease and cancer. Cancer Res. Treat. 2010, 42:125-129.
11. Norris A.D., Calarco J.A. Emerging roles of alternative pre-mRNA splicing regulation in neuronal development and function. Front. Neurosci. 2012, 6:122.
12. Padgett R.A. New connections between splicing and human disease. Trends Genet. 2012, 28:147-154.
13. Baltz A.G., et al. The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. Mol. Cell 2012, 46:674-690.
14. Castelló A., et al. Insights into RNA biology from an atlas of mammalian mRNA-binding proteins. Cell 2012, 149:1393-1406.
15. Scherrer T., et al. A screen for RNA-binding proteins in yeast indicates dual functions for many enzymes. PLoS ONE 2010, 5:e15499.
16. Tsvetanova N.G., et al. Proteome-wide search reveals unexpected RNA-binding proteins in Saccharomyces cerevisiae. PLoS ONE 2010, 5:e12671.
17. Butter F., et al. Unbiased RNA-protein interaction screen by quantitative proteomics. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:10626-10631.
18. Sibley C.R., et al. The greatest catch: big game fishing for mRNA-bound proteins. Genome Biol. 2012, 13:163.
19. Hafner M., et al. Transcriptome-wide identification of RNA-binding protein and microRNA target sites by PAR-CLIP. Cell 2010, 141:129-141.
20. Pollard K.S., et al. Detection of nonneutral substitution rates on mammalian phylogenies. Genome Res. 2010, 20:110-121.
21. Bradfield J.P., et al. A genome-wide association meta-analysis identifies new childhood obesity loci. Nat. Genet. 2012, 44:526-531.
22. Limou S., et al. Genomewide association study of an AIDS-nonprogression cohort emphasizes the role played by HLA genes (ANRS Genomewide Association Study 02). J. Infect. Dis. 2009, 199:419-426.
23. Lima L., et al. Association between FAS polymorphism and prostate cancer development. Prostate Cancer Prostatic Dis. 2008, 11:94-98.
24. Izquierdo J.M. Hu antigen R (HuR) functions as an alternative pre-mRNA splicing regulator of Fas apoptosis-promoting receptor on exon definition. J. Biol. Chem. 2008, 283:19077-19084.
25. Izquierdo J.M. Cell-specific regulation of Fas exon 6 splicing mediated by Hu antigen R. Biochem. Biophys. Res. Commun. 2010, 402:324-328.
26. Izquierdo J.M., et al. Regulation of Fas alternative splicing by antagonistic effects of TIA-1 and PTB on exon definition. Mol. Cell 2005, 19:475-484.
27. Ruggero D. Translational control in cancer etiology. Cold Spring Harb. Perspect. Biol. 2012, 4:a012336.
28. Kapasi P., et al. L13a blocks 48S assembly: role of a general initiation factor in mRNA-specific translational control. Mol. Cell 2007, 25:113-126.
29. Malina A., et al. Emerging therapeutics targeting mRNA translation. Cold Spring Harb. Perspect. Biol. 2012, 4:a012377.
30. Brass A.L., et al. Identification of host proteins required for HIV infection through a functional genomic screen. Science 2008, 319:921-926.
31. Dictenberg J.B., et al. A direct role for FMRP in activity-dependent dendritic mRNA transport links filopodial-spine morphogenesis to fragile X syndrome. Dev. Cell 2008, 14:926-939.
32. Osman A. MicroRNAs in health and disease - basic science and clinical applications. Clin. Lab. 2012, 58:393-402.
33. Danckwardt S., et al. 3' end mRNA processing: molecular mechanisms and implications for health and disease. EMBO J. 2008, 27:482-498.
34. Danckwardt S., et al. 3' end processing of the prothrombin mRNA in thrombophilia. Acta Haematol. 2006, 115:192-197.
35. Szklarczyk D., et al. The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored. Nucleic Acids Res. 2011, 39:D561-D568.
36. von Mering C., et al. STRING: known and predicted protein-protein associations, integrated and transferred across organisms. Nucleic Acids Res. 2005, 33:D433-D437.
37. Costa-Mattioli M., et al. Translational control of long-lasting synaptic plasticity and memory. Neuron 2009, 61:10-26.
38. Gkogkas C., et al. Translational control mechanisms in long-lasting synaptic plasticity and memory. J. Biol. Chem. 2010, 285:31913-31917.
39. Bugiani M., et al. Leukoencephalopathy with vanishing white matter: a review. J. Neuropathol. Exp. Neurol. 2010, 69:987-996.
40. Pavitt G.D., Proud C.G. Protein synthesis and its control in neuronal cells with a focus on vanishing white matter disease. Biochem. Soc. Trans. 2009, 37:1298-1310.
41. Mohammad-Qureshi S.S., et al. Clues to the mechanism of action of eIF2B, the guanine-nucleotide-exchange factor for translation initiation. Biochem. Soc. Trans. 2008, 36:658-664.
42. Garcia M.A., et al. The dsRNA protein kinase PKR: virus and cell control. Biochimie 2007, 89:799-811.
43. Costa-Mattioli M., et al. Translational control of hippocampal synaptic plasticity and memory by the eIF2alpha kinase GCN2. Nature 2005, 436:1166-1173.
44. Costa-Mattioli M., et al. eIF2alpha phosphorylation bidirectionally regulates the switch from short- to long-term synaptic plasticity and memory. Cell 2007, 129:195-206.
45. Lunde B.M., et al. RNA-binding proteins: modular design for efficient function. Nat. Rev. Mol. Cell Biol. 2007, 8:479-490.
46. Sprangers R., et al. High-resolution X-ray and NMR structures of the SMN Tudor domain: conformational variation in the binding site for symmetrically dimethylated arginine residues. J. Mol. Biol. 2003, 327:507-520.
47. Selenko P., et al. SMN tudor domain structure and its interaction with the Sm proteins. Nat. Struct. Biol. 2001, 8:27-31.
48. Sun Y., et al. Molecular and functional analysis of intragenic SMN1 mutations in patients with spinal muscular atrophy. Hum. Mutat. 2005, 25:64-71.
49. Kabashi E., et al. TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nat. Genet. 2008, 40:572-574.
50. Nousbeck J., et al. Alopecia, neurological defects, and endocrinopathy syndrome caused by decreased expression of RBM28, a nucleolar protein associated with ribosome biogenesis. Am. J. Hum. Genet. 2008, 82:1114-1121.
51. Zang J.B., et al. A mouse model of the human fragile X syndrome I304N mutation. PLoS Genet. 2009, 5:e1000758.
52. Stirnimann C.U., et al. WD40 proteins propel cellular networks. Trends Biochem. Sci. 2010, 35:565-574.
53. Lau C.K., et al. Gemin5-snRNA interaction reveals an RNA binding function for WD repeat domains. Nat. Struct. Mol. Biol. 2009, 16:486-491.
54. Batista L.F., et al. Telomere shortening and loss of self-renewal in dyskeratosis congenita induced pluripotent stem cells. Nature 2011, 474:399-402.
55. Dyson H.J., Wright P.E. Intrinsically unstructured proteins and their functions. Nat. Rev. Mol. Cell Biol. 2005, 6:197-208.
56. Tompa P., Csermely P. The role of structural disorder in the function of RNA and protein chaperones. FASEB J. 2004, 18:1169-1175.
57. Han T.W., et al. Cell-free formation of RNA granules: bound RNAs identify features and components of cellular assemblies. Cell 2012, 149:768-779.
58. Kato M., et al. Cell-free formation of RNA granules: low complexity sequence domains form dynamic fibers within hydrogels. Cell 2012, 149:753-767.
59. Phan A.T., et al. Structure-function studies of FMRP RGG peptide recognition of an RNA duplex-quadruplex junction. Nat. Struct. Mol. Biol. 2011, 18:796-804.
60. Darnell J.C., et al. Fragile X mental retardation protein targets G quartet mRNAs important for neuronal function. Cell 2001, 107:489-499.
61. Vance C., et al. Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science 2009, 323:1208-1211.
62. Xin Z.T., et al. Functional characterization of natural telomerase mutations found in patients with hematologic disorders. Blood 2007, 109:524-532.
63. Easton D.F., et al. A systematic genetic assessment of 1,433 sequence variants of unknown clinical significance in the BRCA1 and BRCA2 breast cancer-predisposition genes. Am. J. Hum. Genet. 2007, 81:873-883.
64. Aressy B., Greenberg R.A. DNA damage: placing BRCA1 in the proper context. Curr. Biol. 2012, 22:R806-R808.
65. Hentze M.W., Preiss T. The REM phase of gene regulation. Trends Biochem. Sci. 2010, 35:423-426.
66. Ciesla J. Metabolic enzymes that bind RNA: yet another level of cellular regulatory network?. Acta Biochim. Pol. 2006, 53:11-32.
67. Hentze M.W. Enzymes as RNA-binding proteins: a role for (di)nucleotide-binding domains?. Trends Biochem. Sci. 1994, 19:101-103.
68. Muckenthaler M.U., et al. Systemic iron homeostasis and the iron-responsive element/iron-regulatory protein (IRE/IRP) regulatory network. Annu. Rev. Nutr. 2008, 28:197-213.
69. Hedstrom L. IMP dehydrogenase-linked retinitis pigmentosa. Nucleosides Nucleotides Nucleic Acids 2008, 27:839-849.
70. Rauschenberger K., et al. A non-enzymatic function of 17beta-hydroxysteroid dehydrogenase type 10 is required for mitochondrial integrity and cell survival. EMBO Mol. Med. 2010, 2:51-62.
71. Mortimer S.E., Hedstrom L. Autosomal dominant retinitis pigmentosa mutations in inosine 5'-monophosphate dehydrogenase type I disrupt nucleic acid binding. Biochem. J. 2005, 390:41-47.
72. Mitchell S.F., et al. Global analysis of yeast mRNPs. Nat. Struct. Mol. Biol. 2013, 20:127-133.
73. Wang G.S., Cooper T.A. Splicing in disease: disruption of the splicing code and the decoding machinery. Nat. Rev. Genet. 2007, 8:749-761.
74. Kwiatkowski T.J., et al. Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science 2009, 323:1205-1208.
75. Keller B.A., et al. Co-aggregation of RNA binding proteins in ALS spinal motor neurons: evidence of a common pathogenic mechanism. Acta Neuropathol. 2012, 124:733-747.
76. Cohen S.B., et al. Protein composition of catalytically active human telomerase from immortal cells. Science 2007, 315:1850-1853.
77. Blasco M.A. Telomeres and human disease: ageing, cancer and beyond. Nat. Rev. Genet. 2005, 6:611-622.
78. Shay J.W., Wright W.E. Role of telomeres and telomerase in cancer. Semin. Cancer Biol. 2011, 21:349-353.
79. Cauchi R.J. SMN and Gemins: 'we are family'... or are we?: insights into the partnership between Gemins and the spinal muscular atrophy disease protein SMN. Bioessays 2010, 32:1077-1089.
80. Paushkin S., et al. The SMN complex, an assemblyosome of ribonucleoproteins. Curr. Opin. Cell Biol. 2002, 14:305-312.